From Nunavik to National Stage: A New Chapter for Canada's Drug Strategy

OTTAWA, ON – June 08, 2026 – In the often-staid world of government announcements, the appointment of Isabelle Fortier to the Board of Directors of the Canadian Centre on Substance Use and Addiction (CCSA) represents more than a simple personnel change. It signals a deliberate and necessary strategic pivot. Announced today by Health Minister Marjorie Michel, Fortier’s three-year term brings a voice steeped in the harsh realities of frontline harm reduction and the unique challenges of Canada’s North to a national policy-making body. This is not just an appointment; it is an acknowledgment that the path forward in our fight against substance-related harms must be paved with authentic, on-the-ground experience.

Ms. Fortier, currently the Planning and Programming Officer for Overdose Prevention Response in Nunavik, carries what the official release terms “extensive professional and lived experience.” This is a quiet but powerful phrase. It speaks to a depth of understanding that transcends academic theory and statistical analysis. It suggests an intimacy with the human cost of the overdose crisis, a crisis that continues to evolve with devastating complexity across the country. For an organization like the CCSA, tasked with providing national leadership, this kind of perspective is not just an asset—it is essential.

A Crisis of Many Fronts

To understand the significance of Fortier’s appointment, one must first grasp the fractured landscape of Canada’s substance use crisis. While recent national data offers a glimmer of hope—a 22% reduction in opioid-related deaths and a 38% drop for stimulants between mid-2024 and mid-2025—these figures mask a more complicated and troubling reality. The total number of deaths remains tragically high, a stark reminder that the crisis is far from over. In 2024 alone, over 7,100 people died from opioid-related overdoses, an average of 20 deaths per day.

More importantly, the national decline conceals stark regional disparities. While some provinces have seen decreases, others, including Quebec, Newfoundland and Labrador, and the Northwest Territories, reported a rise in opioid-related deaths in 2024. The crisis is not a monolith; it is a mosaic of localized emergencies, each with its own unique drivers and challenges. Nowhere is this more evident than in Indigenous communities, which continue to be disproportionately impacted by colonization, marginalization, and an unregulated drug supply contaminated with fentanyl. In some regions, Indigenous people are nearly six times more likely to experience opioid-related harm.

This is the context into which Fortier’s expertise from Nunavik becomes so critical. The northern Quebec region has long faced severe challenges, with a 2004 study showing illicit drug use at a rate more than four times the Canadian average. More recent data from 2017 highlighted the highest levels of alcohol consumption within Inuit Nunangat and daily cannabis use at 28%, far exceeding other Inuit regions. The community is grappling with such a severe influx of illicit substances that leaders are exploring drastic measures like banishment for traffickers. This is the environment where policy meets reality, and where solutions must be both innovative and culturally grounded.

The Nunavik Lens: Lived Experience as Policy

Isabelle Fortier’s work is situated at this exact intersection. Her commitment to “carrying forward the voices and experiences of families and loved ones” is a direct challenge to top-down policy models. It champions a community-centric approach, one that recognizes the invaluable expertise of those most affected by the crisis. Her background is a testament to the growing consensus that harm reduction, community engagement, and evidence-based solutions are the pillars of any effective strategy.

This appointment brings a perspective forged in a region with only one nine-bed recovery center—the Isuarsivik Regional Recovery Centre—serving a vast territory, and where services must be offered in Inuktitut to be effective. This is the kind of practical, resource-constrained environment that breeds innovation and underscores the importance of every decision. Bringing this “Nunavik lens” to the CCSA’s 13-member board has the potential to ground national conversations in the lived realities of Canada’s most vulnerable communities, ensuring that strategies are not only evidence-based but also equitable and applicable in diverse contexts.

The Mandate of the CCSA

Established in 1988, the CCSA occupies a unique space in Canada’s public health ecosystem. As a non-governmental organization, it has the independence to provide national leadership and advance solutions while working in close collaboration with government bodies. Its mandate is to bridge the gap between knowledge and practice, synthesizing research to inform public policy. The organization has been instrumental in shaping the national dialogue, a fact underscored by its deliberate shift in language—changing its flagship series from “Substance Abuse in Canada” to “Substance Use in Canada” to actively combat stigma.

Yet, for all its work, the CCSA faces the same monumental challenge as every other organization in this space: the sheer scale and persistence of the overdose crisis. A research and policy analyst with the organization recently noted that despite some positive trends, it is “not time to drop the ball,” emphasizing that deaths remain far higher than when the public health emergency was first declared. Fortier joins the board at a time when the CCSA is actively working with municipalities to build a pan-Canadian playbook. Her experience will be invaluable in ensuring that playbook is flexible, compassionate, and effective for all communities, not just urban centers.

A Merit-Based Mandate for Change

The process of appointing directors through the Governor-in-Council is designed to be open, transparent, and merit-based, bringing highly qualified Canadians into public service. While the system itself has faced scrutiny for its vetting procedures in the past, Fortier's appointment appears to be a textbook example of the process working as intended. It represents a strategic investment in a specific, urgently needed form of expertise.

As Health Minister Marjorie Michel stated, “Her diverse experience in substance use and addiction, harm reduction and community involvement will be a strong asset to the organization.” This is more than a polite endorsement. It is a recognition that the boardroom table needs people who have not only studied the map but have also walked the terrain. By bringing Isabelle Fortier’s voice from the front lines of Nunavik to the national stage, the Government of Canada is not just filling a seat; it is enriching the very nature of the conversation about our country’s substance use strategy.